(+)-schisandrin B multiple interactions ISO Mylk (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MYLK mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MYLK mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO Mylk (Rattus norvegicus) 6480464 [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in increased expression of MYLK mRNA CTD PMID:27840820 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of MYLK mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of MYLK mRNA] CTD PMID:22206623 1,3-dinitrobenzene increases expression ISO Mylk (Rattus norvegicus) 6480464 3-dinitrobenzene results in increased expression of MYLK mRNA CTD PMID:24140754 1,4-dithiothreitol multiple interactions ISO MYLK (Homo sapiens) 6480464 Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased phosphorylation of MYLK protein] CTD PMID:31873818 1-octadec-9-enoylglycero-3-phosphate affects response to substance ISO MYLK (Homo sapiens) 6480464 MYLK protein affects the susceptibility to lysophosphatidic acid CTD PMID:10640419 17alpha-ethynylestradiol decreases expression ISO Mylk (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of MYLK mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO MYLK (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYLK mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol multiple interactions EXP 6480464 Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of MYLK mRNA] CTD PMID:16977382 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO MYLK (Homo sapiens) 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MYLK mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Mylk (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYLK mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYLK mRNA CTD PMID:32553695 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Mylk (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of MYLK mRNA CTD PMID:22298810 and PMID:34747641 2,4,6-tribromophenol decreases expression ISO MYLK (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2-methoxyethanol increases expression ISO Mylk (Rattus norvegicus) 6480464 methyl cellosolve metabolite results in increased expression of MYLK protein CTD PMID:11794376 3-methylcholanthrene multiple interactions EXP 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MYLK mRNA CTD PMID:23519560 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of MYLK mRNA CTD PMID:30951980 4-hydroxynon-2-enal decreases expression ISO MYLK (Homo sapiens) 6480464 4-hydroxy-2-nonenal results in decreased expression of MYLK mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of MYLK mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO MYLK (Homo sapiens) 6480464 Decitabine affects the expression of MYLK mRNA CTD PMID:17145863 6-propyl-2-thiouracil affects expression ISO Mylk (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of MYLK mRNA CTD PMID:24780913 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:32553695 acrolein multiple interactions ISO MYLK (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MYLK mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MYLK mRNA CTD PMID:32699268 acrylamide decreases expression ISO MYLK (Homo sapiens) 6480464 Acrylamide results in decreased expression of MYLK mRNA CTD PMID:32763439 actinomycin D multiple interactions ISO MYLK (Homo sapiens) 6480464 Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK mRNA] and Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK protein] CTD PMID:15701621 afimoxifene decreases expression EXP 6480464 afimoxifene results in decreased expression of MYLK mRNA CTD PMID:26879975 aflatoxin B1 affects expression ISO MYLK (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of MYLK protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO MYLK (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of MYLK exon and Aflatoxin B1 results in increased methylation of MYLK gene CTD PMID:27153756 and PMID:30157460 aflatoxin B1 decreases expression ISO MYLK (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of MYLK mRNA CTD PMID:21632981 more ... aldehydo-D-glucose increases uptake EXP 6480464 MYLK protein results in increased uptake of Glucose CTD PMID:18773891 aldehydo-D-glucose multiple interactions ISO MYLK (Homo sapiens) 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 aldehydo-D-glucose increases expression ISO MYLK (Homo sapiens) 6480464 Glucose results in increased expression of MYLK mRNA and Glucose results in increased expression of MYLK protein CTD PMID:34464088 aldehydo-D-glucose multiple interactions EXP 6480464 ML 7 inhibits the reaction [MYLK protein results in increased uptake of Glucose] and ML 9 inhibits the reaction [MYLK protein results in increased uptake of Glucose] CTD PMID:18773891 all-trans-retinoic acid decreases expression ISO MYLK (Homo sapiens) 6480464 Tretinoin results in decreased expression of MYLK mRNA CTD PMID:21934132 alpha-pinene multiple interactions ISO MYLK (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MYLK mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MYLK mRNA CTD PMID:32699268 antirheumatic drug increases expression ISO MYLK (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of MYLK mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO MYLK (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of MYLK mRNA CTD PMID:33212167 arsenous acid increases expression ISO MYLK (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MYLK mRNA and Arsenic Trioxide results in increased expression of MYLK protein CTD PMID:32683294 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of MYLK protein CTD PMID:32683294 arsenous acid multiple interactions ISO MYLK (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of MYLK mRNA] CTD PMID:32683294 arsenous acid decreases expression ISO MYLK (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MYLK mRNA CTD PMID:26238599 belinostat decreases expression ISO MYLK (Homo sapiens) 6480464 belinostat results in decreased expression of MYLK mRNA CTD PMID:26272509 Benoxacor increases expression EXP 6480464 benoxacor results in increased expression of MYLK mRNA CTD PMID:34850242 benzo[a]pyrene decreases expression ISO MYLK (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of MYLK mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene metabolite results in decreased expression of MYLK mRNA CTD PMID:32553695 benzo[a]pyrene increases methylation ISO MYLK (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of MYLK promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO MYLK (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MYLK 5' UTR CTD PMID:27901495 Benzo[k]fluoranthene decreases expression ISO MYLK (Homo sapiens) 6480464 benzo(k)fluoranthene results in decreased expression of MYLK mRNA CTD PMID:21635667 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of MYLK mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression ISO MYLK (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of MYLK protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of MYLK mRNA CTD PMID:19850644 bisphenol A affects expression ISO Mylk (Rattus norvegicus) 6480464 bisphenol A affects the expression of MYLK mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO MYLK (Homo sapiens) 6480464 bisphenol A results in decreased methylation of MYLK gene CTD PMID:31601247 bisphenol A multiple interactions ISO MYLK (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MYLK gene CTD PMID:31601247 bisphenol A decreases expression ISO Mylk (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of MYLK mRNA CTD PMID:30816183 and PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MYLK mRNA CTD PMID:30951980 and PMID:38074096 bisphenol F affects expression EXP 6480464 bisphenol F affects the expression of MYLK mRNA CTD PMID:30951980 bucladesine multiple interactions ISO MYLK (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYLK mRNA CTD PMID:20823114 butanal decreases expression ISO MYLK (Homo sapiens) 6480464 butyraldehyde results in decreased expression of MYLK mRNA CTD PMID:26079696 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYLK mRNA CTD PMID:37325564 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYLK mRNA CTD PMID:37325564 caffeine affects phosphorylation ISO MYLK (Homo sapiens) 6480464 Caffeine affects the phosphorylation of MYLK protein CTD PMID:35688186 calcitriol multiple interactions ISO MYLK (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of MYLK mRNA CTD PMID:21592394 calcitriol increases expression ISO MYLK (Homo sapiens) 6480464 Calcitriol results in increased expression of MYLK mRNA CTD PMID:21592394 calcium atom increases activity ISO MYLK (Homo sapiens) 6480464 Calcium deficiency results in increased activity of MYLK protein and Calcium results in increased activity of MYLK protein CTD PMID:10640419 and PMID:11054866 calcium atom multiple interactions ISO Mylk (Rattus norvegicus) 6480464 [[Calcium results in increased activity of MYLK protein] which results in increased phosphorylation of MYL9 protein] which results in decreased secretion of REN protein CTD PMID:9618396 calcium atom multiple interactions ISO MYLK (Homo sapiens) 6480464 ML 7 inhibits the reaction [Calcium deficiency results in increased activity of MYLK protein] CTD PMID:11054866 calcium(0) increases activity ISO MYLK (Homo sapiens) 6480464 Calcium deficiency results in increased activity of MYLK protein and Calcium results in increased activity of MYLK protein CTD PMID:10640419 and PMID:11054866 calcium(0) multiple interactions ISO Mylk (Rattus norvegicus) 6480464 [[Calcium results in increased activity of MYLK protein] which results in increased phosphorylation of MYL9 protein] which results in decreased secretion of REN protein CTD PMID:9618396 calcium(0) multiple interactions ISO MYLK (Homo sapiens) 6480464 ML 7 inhibits the reaction [Calcium deficiency results in increased activity of MYLK protein] CTD PMID:11054866 captan decreases expression EXP 6480464 Captan results in decreased expression of MYLK mRNA CTD PMID:31558096 carbachol affects response to substance ISO Mylk (Rattus norvegicus) 6480464 MYLK protein affects the susceptibility to Carbachol CTD PMID:17272850 carbamazepine affects expression ISO MYLK (Homo sapiens) 6480464 Carbamazepine affects the expression of MYLK mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 CGP 52608 multiple interactions ISO MYLK (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MYLK gene] CTD PMID:28238834 chlordecone decreases expression EXP 6480464 Chlordecone results in decreased expression of MYLK mRNA CTD PMID:33711761 chrysene increases expression EXP 6480464 chrysene results in increased expression of MYLK mRNA CTD PMID:26377693 cisplatin increases expression ISO MYLK (Homo sapiens) 6480464 Cisplatin results in increased expression of MYLK mRNA CTD PMID:27392435 cisplatin multiple interactions ISO MYLK (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MYLK mRNA and [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of MYLK mRNA CTD PMID:27392435 and PMID:30871063 cobalt dichloride decreases expression ISO Mylk (Rattus norvegicus) 6480464 cobaltous chloride results in decreased expression of MYLK mRNA and cobaltous chloride results in decreased expression of MYLK protein CTD PMID:24386269 copper atom multiple interactions ISO MYLK (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of MYLK mRNA and [NSC 689534 binds to Copper] which results in increased expression of MYLK mRNA CTD PMID:20971185 and PMID:24690739 copper(0) multiple interactions ISO MYLK (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of MYLK mRNA and [NSC 689534 binds to Copper] which results in increased expression of MYLK mRNA CTD PMID:20971185 and PMID:24690739 crocidolite asbestos decreases expression ISO MYLK (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of MYLK mRNA CTD PMID:25351596 Cuprizon affects expression ISO Mylk (Rattus norvegicus) 6480464 Cuprizone affects the expression of MYLK mRNA CTD PMID:26577399 curcumin increases expression ISO MYLK (Homo sapiens) 6480464 Curcumin results in increased expression of MYLK mRNA CTD PMID:21594647 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [deoxynivalenol results in increased expression of MYLK mRNA] and Curcumin inhibits the reaction [deoxynivalenol results in increased expression of MYLK protein] CTD PMID:35817260 cycloheximide multiple interactions ISO MYLK (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [TNF protein results in increased expression of MYLK protein] CTD PMID:15701621 cyclosporin A decreases expression ISO MYLK (Homo sapiens) 6480464 Cyclosporine results in decreased expression of MYLK mRNA CTD PMID:20106945 and PMID:27989131 cyclosporin A affects expression ISO MYLK (Homo sapiens) 6480464 Cyclosporine affects the expression of MYLK mRNA CTD PMID:25562108 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of MYLK mRNA CTD PMID:19770486 D-glucose multiple interactions EXP 6480464 ML 7 inhibits the reaction [MYLK protein results in increased uptake of Glucose] and ML 9 inhibits the reaction [MYLK protein results in increased uptake of Glucose] CTD PMID:18773891 D-glucose multiple interactions ISO MYLK (Homo sapiens) 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 D-glucose increases expression ISO MYLK (Homo sapiens) 6480464 Glucose results in increased expression of MYLK mRNA and Glucose results in increased expression of MYLK protein CTD PMID:34464088 D-glucose increases uptake EXP 6480464 MYLK protein results in increased uptake of Glucose CTD PMID:18773891 decabromodiphenyl ether increases expression ISO MYLK (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of MYLK protein CTD PMID:33675858 decabromodiphenyl ether multiple interactions ISO MYLK (Homo sapiens) 6480464 Luteolin inhibits the reaction [decabromobiphenyl ether results in increased expression of MYLK protein] and triptolide inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in increased expression of MYLK protein]] CTD PMID:33675858 deoxynivalenol multiple interactions EXP 6480464 Curcumin inhibits the reaction [deoxynivalenol results in increased expression of MYLK mRNA] and Curcumin inhibits the reaction [deoxynivalenol results in increased expression of MYLK protein] CTD PMID:35817260 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of MYLK mRNA and deoxynivalenol results in increased expression of MYLK protein CTD PMID:35817260 dexamethasone increases expression ISO MYLK (Homo sapiens) 6480464 Dexamethasone results in increased expression of MYLK mRNA CTD PMID:25047013 diarsenic trioxide decreases expression ISO MYLK (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MYLK mRNA CTD PMID:26238599 diarsenic trioxide multiple interactions ISO MYLK (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of MYLK mRNA] CTD PMID:32683294 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of MYLK protein CTD PMID:32683294 diarsenic trioxide increases expression ISO MYLK (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MYLK mRNA and Arsenic Trioxide results in increased expression of MYLK protein CTD PMID:32683294 dimethylarsinous acid decreases expression ISO MYLK (Homo sapiens) 6480464 dimethylarsinous acid results in decreased expression of MYLK mRNA CTD PMID:16507463 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYLK mRNA CTD PMID:30529165 disulfiram multiple interactions ISO MYLK (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of MYLK mRNA CTD PMID:24690739 diuron decreases expression ISO Mylk (Rattus norvegicus) 6480464 Diuron results in decreased expression of MYLK mRNA CTD PMID:25152437 diuron increases expression ISO Mylk (Rattus norvegicus) 6480464 Diuron results in increased expression of MYLK mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO MYLK (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO Mylk (Rattus norvegicus) 6480464 Doxorubicin results in decreased expression of MYLK protein CTD PMID:12717111 doxorubicin decreases expression ISO MYLK (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MYLK mRNA CTD PMID:29803840 emodin increases activity ISO Mylk (Rattus norvegicus) 6480464 Emodin results in increased activity of MYLK protein CTD PMID:15133857 endosulfan decreases expression ISO Mylk (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of MYLK mRNA CTD PMID:29391264 and PMID:31464424 entinostat decreases expression ISO MYLK (Homo sapiens) 6480464 entinostat results in decreased expression of MYLK mRNA CTD PMID:26272509 entinostat multiple interactions ISO MYLK (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYLK mRNA CTD PMID:27188386 ethanol increases expression ISO MYLK (Homo sapiens) 6480464 Ethanol results in increased expression of MYLK mRNA CTD PMID:25226407 ethanol multiple interactions ISO MYLK (Homo sapiens) 6480464 ML 7 inhibits the reaction [Ethanol results in increased activity of MYLK protein] CTD PMID:10198341 ethanol increases activity ISO MYLK (Homo sapiens) 6480464 Ethanol results in increased activity of MYLK protein CTD PMID:10198341 fenofibrate decreases expression ISO MYLK (Homo sapiens) 6480464 Fenofibrate results in decreased expression of MYLK mRNA CTD PMID:25572481 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of MYLK mRNA] CTD PMID:22206623 folpet decreases expression EXP 6480464 folpet results in decreased expression of MYLK mRNA CTD PMID:31558096 FR900359 affects phosphorylation ISO MYLK (Homo sapiens) 6480464 FR900359 affects the phosphorylation of MYLK protein CTD PMID:37730182 fulvestrant multiple interactions ISO MYLK (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MYLK gene CTD PMID:31601247 furan decreases expression ISO Mylk (Rattus norvegicus) 6480464 furan results in decreased expression of MYLK mRNA CTD PMID:25539665 genistein decreases expression ISO MYLK (Homo sapiens) 6480464 Genistein results in decreased expression of MYLK mRNA CTD PMID:22228119 gentamycin decreases expression ISO Mylk (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of MYLK mRNA CTD PMID:33387578 ginsenoside Re affects expression ISO Mylk (Rattus norvegicus) 6480464 ginsenoside Re affects the expression of MYLK mRNA and ginsenoside Re affects the expression of MYLK protein CTD PMID:24658813 glafenine decreases expression ISO Mylk (Rattus norvegicus) 6480464 Glafenine results in decreased expression of MYLK mRNA CTD PMID:24136188 glucose multiple interactions EXP 6480464 ML 7 inhibits the reaction [MYLK protein results in increased uptake of Glucose] and ML 9 inhibits the reaction [MYLK protein results in increased uptake of Glucose] CTD PMID:18773891 glucose increases expression ISO MYLK (Homo sapiens) 6480464 Glucose results in increased expression of MYLK mRNA and Glucose results in increased expression of MYLK protein CTD PMID:34464088 glucose multiple interactions ISO MYLK (Homo sapiens) 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 glucose increases uptake EXP 6480464 MYLK protein results in increased uptake of Glucose CTD PMID:18773891 hydrogen peroxide affects expression ISO MYLK (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of MYLK mRNA CTD PMID:23410634 Indeno[1,2,3-cd]pyrene decreases expression ISO MYLK (Homo sapiens) 6480464 indeno(1 more ... CTD PMID:21635667 indometacin increases expression ISO MYLK (Homo sapiens) 6480464 Indomethacin results in increased expression of MYLK mRNA CTD PMID:24737281 ivermectin decreases expression ISO MYLK (Homo sapiens) 6480464 Ivermectin results in decreased expression of MYLK protein CTD PMID:32959892 L-1,4-dithiothreitol multiple interactions ISO MYLK (Homo sapiens) 6480464 Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased phosphorylation of MYLK protein] CTD PMID:31873818 lipopolysaccharide multiple interactions EXP 6480464 Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of MYLK mRNA] more ... CTD PMID:16977382 and PMID:19374788 lipopolysaccharide multiple interactions ISO MYLK (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MYLK mRNA CTD PMID:35811015 lipopolysaccharide affects response to substance ISO Mylk (Rattus norvegicus) 6480464 MYLK protein affects the susceptibility to Lipopolysaccharides CTD PMID:16192642 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of MYLK mRNA and Lipopolysaccharides results in increased expression of MYLK protein CTD PMID:16977382 and PMID:19374788 loperamide decreases expression EXP 6480464 Loperamide results in decreased expression of MYLK mRNA CTD PMID:37375548 loperamide multiple interactions EXP 6480464 Foeniculum vulgare fruit inhibits the reaction [Loperamide results in decreased expression of MYLK mRNA] and mosapride inhibits the reaction [Loperamide results in decreased expression of MYLK mRNA] CTD PMID:37375548 losartan multiple interactions ISO Mylk (Rattus norvegicus) 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of MYLK protein] CTD PMID:18511912 luteolin multiple interactions ISO MYLK (Homo sapiens) 6480464 Luteolin inhibits the reaction [decabromobiphenyl ether results in increased expression of MYLK protein] and triptolide inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in increased expression of MYLK protein]] CTD PMID:33675858 medroxyprogesterone acetate multiple interactions ISO MYLK (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYLK mRNA CTD PMID:20823114 menadione affects expression ISO MYLK (Homo sapiens) 6480464 Vitamin K 3 affects the expression of MYLK mRNA CTD PMID:23410634 mercury dibromide decreases expression ISO MYLK (Homo sapiens) 6480464 mercuric bromide results in decreased expression of MYLK mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO MYLK (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYLK mRNA CTD PMID:27188386 methamphetamine affects expression ISO Mylk (Rattus norvegicus) 6480464 Methamphetamine affects the expression of MYLK mRNA CTD PMID:19564919 methamphetamine multiple interactions ISO Mylk (Rattus norvegicus) 6480464 [Methamphetamine co-treated with SCH 23390] affects the expression of MYLK mRNA CTD PMID:19564919 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of MYLK mRNA CTD PMID:26307267 methapyrilene decreases expression ISO Mylk (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of MYLK mRNA CTD PMID:30467583 methidathion decreases expression EXP 6480464 methidathion results in decreased expression of MYLK mRNA CTD PMID:34813904 methoxyacetic acid increases expression ISO Mylk (Rattus norvegicus) 6480464 methoxyacetic acid results in increased expression of MYLK protein CTD PMID:11794376 methoxychlor affects methylation ISO Mylk (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of MYLK gene CTD PMID:35440735 methylmercury chloride decreases expression ISO MYLK (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of MYLK mRNA CTD PMID:28001369 ML-7 decreases activity ISO MYLK (Homo sapiens) 6480464 [ML 7 results in decreased activity of MYLK protein] which results in decreased activity of F2 protein and ML 7 results in decreased activity of MYLK protein CTD PMID:10733514 more ... ML-7 multiple interactions ISO Mylk (Rattus norvegicus) 6480464 [[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein] which results in increased secretion of REN protein and [ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein CTD PMID:18835913 and PMID:9618396 ML-7 decreases activity EXP 6480464 ML 7 results in decreased activity of MYLK protein CTD PMID:19943851 ML-7 decreases activity ISO Mylk (Rattus norvegicus) 6480464 ML 7 results in decreased activity of MYLK protein CTD PMID:17541957 ML-7 multiple interactions EXP 6480464 ML 7 inhibits the reaction [Lipopolysaccharides results in increased expression of MYLK mRNA] more ... CTD PMID:18773891 and PMID:19374788 ML-7 multiple interactions ISO MYLK (Homo sapiens) 6480464 [ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein more ... CTD PMID:10198341 more ... mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of MYLK mRNA CTD PMID:38113427 mosapride citrate dihydrate multiple interactions EXP 6480464 mosapride inhibits the reaction [Loperamide results in decreased expression of MYLK mRNA] CTD PMID:37375548 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of MYLK mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium decreases expression ISO Mylk (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MYLK mRNA CTD PMID:28801915 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO MYLK (Homo sapiens) 6480464 Methylnitronitrosoguanidine results in decreased expression of MYLK mRNA CTD PMID:12634122 nickel atom increases expression EXP 6480464 Nickel results in increased expression of MYLK mRNA CTD PMID:18922574 nickel atom decreases expression ISO MYLK (Homo sapiens) 6480464 Nickel results in decreased expression of MYLK mRNA CTD PMID:24768652 and PMID:25583101 Nor-9-carboxy-delta9-THC multiple interactions ISO MYLK (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MYLK gene CTD PMID:30521419 ouabain decreases expression ISO MYLK (Homo sapiens) 6480464 Ouabain results in decreased expression of MYLK mRNA CTD PMID:28795476 oxaliplatin multiple interactions ISO Mylk (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MYLK mRNA CTD PMID:25729387 ozone multiple interactions ISO MYLK (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MYLK mRNA more ... CTD PMID:32699268 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MYLK mRNA CTD PMID:34911549 p-chloromercuribenzoic acid decreases expression ISO MYLK (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of MYLK mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO MYLK (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYLK mRNA CTD PMID:27188386 panobinostat multiple interactions ISO MYLK (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYLK mRNA CTD PMID:27188386 panobinostat decreases expression ISO MYLK (Homo sapiens) 6480464 panobinostat results in decreased expression of MYLK mRNA CTD PMID:26272509 paracetamol decreases expression ISO MYLK (Homo sapiens) 6480464 Acetaminophen results in decreased expression of MYLK mRNA CTD PMID:21420995 more ... paracetamol increases expression ISO Mylk (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of MYLK mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MYLK mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MYLK mRNA CTD PMID:36331819 phenylmercury acetate decreases expression ISO MYLK (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of MYLK mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO MYLK (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYLK mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MYLK mRNA CTD PMID:23519560 pioglitazone multiple interactions EXP 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYLK mRNA CTD PMID:27935865 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MYLK mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of MYLK mRNA CTD PMID:23811191 progesterone multiple interactions ISO MYLK (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of MYLK mRNA and [Progesterone co-treated with Estradiol] results in decreased expression of MYLK mRNA CTD PMID:17404688 and PMID:20660070 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of MYLK mRNA CTD PMID:21278054 quercetin decreases expression ISO MYLK (Homo sapiens) 6480464 Quercetin results in decreased expression of MYLK mRNA CTD PMID:21632981 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO MYLK (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of MYLK mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO MYLK (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MYLK mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO MYLK (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 decreases expression ISO Mylk (Rattus norvegicus) 6480464 SCH 23390 results in decreased expression of MYLK mRNA CTD PMID:19564919 SCH 23390 multiple interactions ISO Mylk (Rattus norvegicus) 6480464 [Methamphetamine co-treated with SCH 23390] affects the expression of MYLK mRNA CTD PMID:19564919 silicon dioxide decreases expression ISO MYLK (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of MYLK mRNA CTD PMID:25351596 sirolimus multiple interactions ISO MYLK (Homo sapiens) 6480464 Sirolimus inhibits the reaction [TP73 protein results in increased expression of MYLK mRNA] CTD PMID:21245298 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of MYLK mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO MYLK (Homo sapiens) 6480464 sodium arsenite results in decreased expression of MYLK mRNA CTD PMID:16507463 sodium arsenite decreases expression ISO Mylk (Rattus norvegicus) 6480464 sodium arsenite results in decreased expression of MYLK mRNA and sodium arsenite results in decreased expression of MYLK protein CTD PMID:29459688 and PMID:35314868 sodium dichromate affects expression ISO Mylk (Rattus norvegicus) 6480464 sodium bichromate affects the expression of MYLK mRNA CTD PMID:22110744 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of MYLK mRNA CTD PMID:31558096 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of MYLK protein CTD PMID:28918527 succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MYLK mRNA CTD PMID:26378955 sulforaphane decreases expression ISO MYLK (Homo sapiens) 6480464 sulforaphane results in decreased expression of MYLK mRNA CTD PMID:31838189 telmisartan multiple interactions ISO MYLK (Homo sapiens) 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 temozolomide decreases expression ISO MYLK (Homo sapiens) 6480464 Temozolomide results in decreased expression of MYLK mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO MYLK (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of MYLK mRNA CTD PMID:12419474 tert-butyl hydroperoxide affects expression ISO MYLK (Homo sapiens) 6480464 tert-Butylhydroperoxide affects the expression of MYLK mRNA CTD PMID:23410634 testosterone multiple interactions ISO MYLK (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of MYLK mRNA CTD PMID:21592394 testosterone increases expression ISO MYLK (Homo sapiens) 6480464 Testosterone results in increased expression of MYLK mRNA CTD PMID:21592394 tetrachloromethane multiple interactions ISO Mylk (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MYLK mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO Mylk (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of MYLK mRNA CTD PMID:31150632 thalidomide increases expression EXP 6480464 Thalidomide results in increased expression of MYLK mRNA CTD PMID:26217789 thioacetamide decreases expression ISO Mylk (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of MYLK mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of MYLK mRNA CTD PMID:23557971 and PMID:32333507 titanium dioxide increases methylation ISO MYLK (Homo sapiens) 6480464 titanium dioxide results in increased methylation of MYLK gene CTD PMID:34973136 titanium dioxide decreases expression ISO MYLK (Homo sapiens) 6480464 titanium dioxide results in decreased expression of MYLK mRNA CTD PMID:34973136 topotecan multiple interactions ISO Mylk (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MYLK mRNA CTD PMID:25729387 topotecan increases expression ISO Mylk (Rattus norvegicus) 6480464 Topotecan results in increased expression of MYLK mRNA CTD PMID:25729387 trichostatin A increases expression ISO MYLK (Homo sapiens) 6480464 trichostatin A results in increased expression of MYLK mRNA CTD PMID:24935251 and PMID:26238599 trichostatin A multiple interactions ISO MYLK (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYLK mRNA CTD PMID:27188386 trichostatin A decreases expression ISO MYLK (Homo sapiens) 6480464 trichostatin A results in decreased expression of MYLK mRNA CTD PMID:24935251 and PMID:26272509 triphenyl phosphate affects expression ISO Mylk (Rattus norvegicus) 6480464 triphenyl phosphate affects the expression of MYLK mRNA CTD PMID:30589522 Triptolide multiple interactions ISO MYLK (Homo sapiens) 6480464 triptolide inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in increased expression of MYLK protein]] CTD PMID:33675858 triptonide increases expression EXP 6480464 triptonide results in increased expression of MYLK mRNA CTD PMID:33045310 urethane decreases expression ISO MYLK (Homo sapiens) 6480464 Urethane results in decreased expression of MYLK mRNA CTD PMID:28818685 valproic acid affects expression ISO MYLK (Homo sapiens) 6480464 Valproic Acid affects the expression of MYLK mRNA CTD PMID:25979313 valproic acid multiple interactions ISO MYLK (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYLK mRNA CTD PMID:27188386 valproic acid decreases expression ISO MYLK (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MYLK mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO MYLK (Homo sapiens) 6480464 Valproic Acid results in increased expression of MYLK mRNA CTD PMID:23179753 more ... vasopressin affects response to substance ISO Mylk (Rattus norvegicus) 6480464 MYLK protein affects the susceptibility to Vasopressins CTD PMID:15347643 vinclozolin affects expression ISO Mylk (Rattus norvegicus) 6480464 vinclozolin affects the expression of MYLK mRNA CTD PMID:19015723 vorinostat increases expression ISO MYLK (Homo sapiens) 6480464 vorinostat results in increased expression of MYLK mRNA CTD PMID:26238599
